Caliway's CBL-514 Receives Early IND Clearance in China, Accelerating Development in the World's Fastest-Growing Body Contouring Market
China Clinical Trial Cleared Ahead of Schedule—CBL-514's China clinical study (CBL-0102) received authorization to proceed from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) ahead of the...


















